Cargando…

"Present and future of immunotherapy in Neuroendocrine Tumors"

Immunotherapy, so promising in many neoplasms, still does not have a precise role in the treatment of neuroendocrine neoplasms (NENs). In this article, we provide an overview on the current knowledge about immunotherapy with immune checkpoint inhibitors (ICIs) applied to NENs, evaluating future pers...

Descripción completa

Detalles Bibliográficos
Autores principales:	Albertelli, Manuela, Dotto, Andrea, Nista, Federica, Veresani, Alessandro, Patti, Luca, Gay, Stefano, Sciallero, Stefania, Boschetti, Mara, Ferone, Diego
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346388/ https://www.ncbi.nlm.nih.gov/pubmed/33851319 http://dx.doi.org/10.1007/s11154-021-09647-z

Ejemplares similares

Impact of Vitamin D Deficiency on Tumor Aggressiveness in Neuroendocrine Neoplasms
por: Albertelli, Manuela, et al.
Publicado: (2023)

Trabecular Bone Score as a Reliable Measure of Lumbar Spine Bone Microarchitecture in Acromegalic Patients
por: Nazzari, Elena, et al.
Publicado: (2022)

Biological and Biochemical Basis of the Differential Efficacy of First and Second Generation Somatostatin Receptor Ligands in Neuroendocrine Neoplasms
por: Gatto, Federico, et al.
Publicado: (2019)

GH Replacement in the Elderly: Is It Worth It?
por: Ricci Bitti, Silvia, et al.
Publicado: (2021)

Left Ventricular Mass Reduction by a Low-Sodium Diet in Treated Hypertensive Patients †
por: Musso, Natale, et al.
Publicado: (2020)

Modulatory activity of testosterone on growth pattern and IGF-1 levels in vanishing testis syndrome: a case report during 15 years of follow-up
por: Franco, Marta, et al.
Publicado: (2023)

Impact of microscopic extrathyroidal extension on differentiated thyroid cancer post-surgical risk of recurrence: a retrospective analysis
por: Patti, L., et al.
Publicado: (2023)

Octreotide-Resistant Acromegaly: Challenges and Solutions
por: Corica, Giuliana, et al.
Publicado: (2020)

Sodium Intake and Target Organ Damage in Hypertension—An Update about the Role of a Real Villain
por: Nista, Federica, et al.
Publicado: (2020)

An unusual cause of adrenal insufficiency with elevation of 17-hydroxyprogesterone: case report
por: Teti, Claudia, et al.
Publicado: (2023)

Insights into Mechanisms of Tumorigenesis in Neuroendocrine Neoplasms
por: Pastorino, Lorenza, et al.
Publicado: (2021)

2-[(18)F]FDG PET in the Management of Radioiodine Refractory Differentiated Thyroid Cancer in the Era of Thyrosin-Kinases Inhibitors: A Real-Life Retrospective Study
por: Gay, Stefano, et al.
Publicado: (2022)

Emerging Targets in Pituitary Adenomas: Role of the CXCL12/CXCR4-R7 System
por: Barbieri, Federica, et al.
Publicado: (2014)

Acromegaly Management in a Tertiary Referral Center After 1 Year of the Coronavirus 2019 Pandemic: A Double Challenge
por: Gatto, Federico, et al.
Publicado: (2021)

Anti-proliferative and anti-secretory effects of everolimus on human pancreatic neuroendocrine tumors primary cultures: is there any benefit from combination with somatostatin analogs?
por: Mohamed, Amira, et al.
Publicado: (2017)

PRRT: identikit of the perfect patient
por: Albertelli, M., et al.
Publicado: (2020)

The role of immunotherapy in microsatellites stable metastatic colorectal cancer: state of the art and future perspectives
por: Gandini, Annalice, et al.
Publicado: (2023)

Landscape and Future Perspectives of Immunotherapy in Neuroendocrine Neoplasia
por: Maggio, Ilaria, et al.
Publicado: (2020)

Pathology Reporting in Neuroendocrine Neoplasms of the Digestive System: Everything You Always Wanted to Know but Were Too Afraid to Ask
por: Albertelli, Manuela, et al.
Publicado: (2021)

Clinical and Radiological Predictors of Biochemical Response to First-Line Treatment With Somatostatin Receptor Ligands in Acromegaly: A Real-Life Perspective
por: Nista, Federica, et al.
Publicado: (2021)

Octreotide and Pasireotide Combination Treatment in Somatotroph Tumor Cells: Predominant Role of SST(2) in Mediating Ligand Effects
por: Amarù, Jessica, et al.
Publicado: (2021)

Immunotherapy for Pemphigus: Present and Future
por: Yuan, Huijie, et al.
Publicado: (2022)

Circulating Neuroendocrine Tumor Biomarkers: Past, Present and Future
por: Komarnicki, Paweł, et al.
Publicado: (2022)

Allergen Immunotherapy: Past, Present, and Future
por: Jutel, Marek, et al.
Publicado: (2016)

Allergen immunotherapy: past, present and future
por: Durham, Stephen R., et al.
Publicado: (2022)

Diabetic Hepatosclerosis Presenting With Severe Cholestasis
por: Nazzari, Elena, et al.
Publicado: (2013)

From microbiota toward gastro-enteropancreatic neuroendocrine neoplasms: Are we on the highway to hell?
por: Vitale, Giovanni, et al.
Publicado: (2020)

Somatostatin Analogues in the Treatment of Neuroendocrine Tumors: Past, Present and Future
por: Stueven, Anna Kathrin, et al.
Publicado: (2019)

Impact of formalin fixation on mismatch repair protein evaluation by immunohistochemistry
por: Grillo, Federica, et al.
Publicado: (2023)

Neuroendocrine neoplasms of the esophagus and stomach
por: Mastracci, Luca, et al.
Publicado: (2021)

Immunotherapy for Alzheimer’s disease: past, present and future
por: Spencer, Brian, et al.
Publicado: (2014)

Combining radiotherapy with immunotherapy: the past, the present and the future
por: Van Limbergen, Evert J, et al.
Publicado: (2017)

Immunotherapy in hematologic malignancies: past, present, and future
por: Im, Annie, et al.
Publicado: (2017)

Past, present, and future of allergen immunotherapy vaccines
por: Dorofeeva, Yulia, et al.
Publicado: (2020)

The Present and Future of Allergen Immunotherapy in Personalized Medicine
por: Ridolo, Erminia, et al.
Publicado: (2022)

Clinical Management of Neuroendocrine Neoplasms in Clinical Practice: A Formal Consensus Exercise
por: Bartolomei, Mirco, et al.
Publicado: (2022)

Diagnostic, Prognostic, and Predictive Role of Ki67 Proliferative Index in Neuroendocrine and Endocrine Neoplasms: Past, Present, and Future
por: La Rosa, Stefano
Publicado: (2023)

Potential new applications of immunotherapy for neuroendocrine neoplasms: immune landscape, current status and future perspectives
por: Bai, Rilan, et al.
Publicado: (2022)

The Challenge of Evaluating Response to Peptide Receptor Radionuclide Therapy in Gastroenteropancreatic Neuroendocrine Tumors: The Present and the Future
por: Liberini, Virginia, et al.
Publicado: (2020)

Immunotherapy for liver tumors: present status and future prospects
por: Matar, Pablo, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_82bt24t825hfp9l8i57i9r6pns